Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 2701 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2 |
| 2702 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 2 |
| 2703 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 4 |
| 2704 | Cord Tissue | Allogeneic – Unrelated | Lack Of Expected Normal Physical Development | Neurology | 2022 | Experimental Therapy | Poland | 7 |
| 2705 | Cord Tissue | Allogeneic – Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 47 |
| 2706 | Cord Tissue | Allogeneic – Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 22 |
| 2707 | Cord Tissue | Allogeneic – Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 49 |
| 2708 | Cord Tissue | Allogeneic – Unrelated | Meniscus Damage | Orthopedy | 2022 | Experimental Therapy | Poland | 54 |
| 2709 | Cord Tissue | Allogeneic – Unrelated | Muscular Dystrophy | Neurology | 2022 | Experimental Therapy | Poland | 62 |
| 2710 | Cord Tissue | Allogeneic – Unrelated | Myelomeningocele | Neurology | 2022 | Experimental Therapy | Poland | 2 |
| 2711 | Cord Tissue | Allogeneic – Unrelated | Myelomeningocele | Neurology | 2022 | Experimental Therapy | Poland | 1 |
| 2712 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 25 |
| 2713 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 14 |
| 2714 | Cord Tissue | Allogeneic – Unrelated | Optic Atrophy | Ophthalmology | 2022 | Experimental Therapy | Poland | 26 |
| 2715 | Cord Tissue | Allogeneic – Unrelated | Ovarian Dysfunction | Gynecology | 2022 | Experimental Therapy | Poland | 37 |
| 2716 | Cord Tissue | Allogeneic – Unrelated | Premature Ovarian Failure; Status After Oncological Treatment Of Breast Cancer | Gynecology | 2022 | Experimental Therapy | Poland | 45 |
| 2717 | Cord Tissue | Allogeneic – Unrelated | Sclerosis Multiplex | Neurology | 2022 | Experimental Therapy | Poland | 41 |
| 2718 | Cord Tissue | Allogeneic – Unrelated | Sequelae Of Spinal Cord Injury; Condition After A Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 23 |
| 2719 | Cord Tissue | Allogeneic – Unrelated | Spasmic Paralysis Of The Limbs | Neurology | 2022 | Experimental Therapy | Poland | 33 |
| 2720 | Cord Tissue | Allogeneic – Unrelated | Spastic Limb Paralysis | Neurology | 2022 | Experimental Therapy | Poland | 30 |
| 2721 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 12 |
| 2722 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 20 |
| 2723 | Cord Tissue | Allogeneic – Unrelated | Spinal Cord Injury | Neurology | 2022 | Experimental Therapy | Poland | 39 |
| 2724 | Cord Tissue | Allogeneic – Unrelated | Spinocerebellar Ataxia | Neurology | 2022 | Experimental Therapy | Poland | 35 |
| 2725 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Germany | 46 |
| 2726 | Cord Blood | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 2727 | Cord Blood | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Germany | 2 |
| 2728 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Poland | 7 |
| 2729 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Hungary | 13 |
| 2730 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Poland | 8 |
| 2731 | Cord Blood | Autologous | Autism | Neurology | 2022 | Experimental Therapy | Romania | 5 |
| 2732 | Cord Blood | Allogeneic – Related | Cerebral Palsy | Neurology | 2022 | Experimental Therapy | UK | 11 |
| 2733 | Cord Blood | Allogeneic – Related | Chronic Myelogenous Leukemia | Hematology | 2022 | Standard Therapy | Turkey | 19 |
| 2734 | Cord Blood | Autologous | Hydrocephalus | Neurology | 2022 | Experimental Therapy | Romania | 6 |
| 2735 | Cord Blood | Allogeneic – Related | Sickle Cell Anemia | Hematology | 2022 | Standard Therapy | Turkey | 7 |
| 2736 | Cord Blood | Allogeneic – Related | Thalassemia Major | Hematology | 2022 | Standard Therapy | Turkey | 19 |
| 2737 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2738 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2739 | Bone Marrow Family | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 1 |
| 2740 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 2741 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2742 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 79 |
| 2743 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 23 |
| 2744 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2745 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2746 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 56 |
| 2747 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 46 |
| 2748 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |
| 2749 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2750 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 43 |
| 2751 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2752 | Bone Marrow Family | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 65 |
| 2753 | Bone Marrow Family | Allogeneic | B-Cell Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 54 |
| 2754 | Bone Marrow Family | Allogeneic | Blastic Plasmacytoid Dendritic Cell Neoplasm | Hematology | 2022 | Standard Therapy | Poland | 55 |
| 2755 | Bone Marrow Family | Allogeneic | Chronic Granulomatous Disease | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2756 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 60 |
| 2757 | Bone Marrow Family | Allogeneic | Chronic Myelomonocytic Leukemia, Type 2 | Hematology | 2022 | Standard Therapy | Poland | 68 |
| 2758 | Bone Marrow Family | Allogeneic | Leukocyte Adhesion Deficiency | Hematology | 2022 | Standard Therapy | Poland | 33 |
| 2759 | Bone Marrow Family | Allogeneic | Mycosis Fungoides | Hematology | 2022 | Standard Therapy | Poland | 62 |
| 2760 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2761 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 66 |
| 2762 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 29 |
| 2763 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 67 |
| 2764 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 71 |
| 2765 | Bone Marrow Family | Allogeneic | Myelodysplastic Syndrome | Hematology | 2022 | Standard Therapy | Poland | 69 |
| 2766 | Bone Marrow Family | Allogeneic | Myelofibrosis | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2767 | Bone Marrow Family | Allogeneic | Myelofibrosis Post Essential Thrombocythemia | Hematology | 2022 | Standard Therapy | Poland | 64 |
| 2768 | Bone Marrow Family | Allogeneic | Myeloma Multiplex | Hematology | 2022 | Standard Therapy | Poland | 49 |
| 2769 | Bone Marrow Family | Allogeneic | T-Cell Non-Hodgkin Lymphoma | Hematology | 2022 | Standard Therapy | Poland | 73 |
| 2770 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 3 |
| 2771 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 2 |
| 2772 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 37 |
| 2773 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 16 |
| 2774 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 9 |
| 2775 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 14 |
| 2776 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2777 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 2778 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 38 |
| 2779 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 2780 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 10 |
| 2781 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 2782 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 4 |
| 2783 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 25 |
| 2784 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 8 |
| 2785 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 6 |
| 2786 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 20 |
| 2787 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 2788 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 13 |
| 2789 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 2790 | Bone Marrow | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2791 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 15 |
| 2792 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2793 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2794 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 11 |
| 2795 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 12 |
| 2796 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 44 |
| 2797 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 18 |
| 2798 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 75 |
| 2799 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 61 |
| 2800 | Bone Marrow | Allogeneic | Acute Myeloid Leukemia | Hematology | 2022 | Standard Therapy | Poland | 41 |